First Star Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Board seatDrew Volpe· per SEC Form D
Co-investorsAngelini VenturesTaiwania CapitalDebiopharm Innovation FundScaleX Venturesredalpine
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.